Age-related changes in growth hormone secretion: Should the somatopause be treated?

Seminars in Reproductive Endocrinology

Volumn 17, Issue 4, 1999, Pages 311-325

  Cummings, David E ^a   Merriam, George R ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Aging; GH deficiency; GH releasing hormone (GHRH); Growth hormone (GH, somatotropin); Pituitary

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SEX HORMONE;

AEROBIC CAPACITY; AGING; BODY FAT; CANCER RISK; CARPAL TUNNEL SYNDROME; DRUG RESPONSE; EDEMA; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HYPOPITUITARISM; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

AGED; AGING; BODY COMPOSITION; CARPAL TUNNEL SYNDROME; EDEMA; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MIDDLE AGED; PITUITARY GLAND;

EID: 0033508314     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016241     Document Type: Article

References (74)

1. Raben MS. Clinical use of human growth hormone. N Engl J Med 1962;266:82-86
2. Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of GH secretion in man: Importance of endogenous estradiol Metab concentrations. J Clin Endocrinol 1987;64:51-58
3. Martha PM Jr, Rogol AD, Veldhuis JD. Alterations in the pulsatile properties of circulating GH concentrations during puberty in boys. J Clin Endocrinol Metab 1989;69:563-570
4. Corpas E, Harman SM, Blackman MR. Human GH and human aging. Endocr Rev 1993;14:20-39
5. Cummings D, Merriam GR. Growth hormone and growth hormone secretagogues in adults. In: Meikle AW, ed. Contemporary Endocrinology: Hormone Replacement Therapy. Totowa, NJ: Humana Press; 1999:61-88
6. Rudman D, Feller AG, Nagraj HS, et al. Effect of human GH in men over 60 years old. N Engl J Med 1990;323:1-6
7. Gelato MC, Merriam GR. Growth hormone-releasing hormone. Annu Rev Physiol 1986;48:569-591
8. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human. Endocr Rev 1998;19:717-797
9. Bowers CY, Veeraragavan K, Sethumadhavan K. Atypical GH releasing peptides. In: Bercu BB, Walker RF. Growth Hormone: Basic and Clinical Aspects. New York: Springer-Verlag; 1994:203-222
10. Patchett AA, Nargund RP, Tata JR, et al. Design and biological activities of L-163,191 (MK-0677), a potent, orally active GH secretagogue. Proc Natl Acad Sci U S A 1995;92:7001-7005
11. Mericq V, Cassorla F, Garcia H, et al. Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children. J Clin Endocrinol Metab 1995;80:1681-1684
12. Mericq VG, Salazar T, Avila A, et al. Effects of eight months' treatment with graded doses of growth hormone-releasing peptide in growth hormone-deficient children. J Clin Endocrinol Metab 1998;83:2355-2360
13. Pandya N, DeMott-Friberg R, Bowers CY, et al. Growth hormone-releasing peptide-6 requires endogenous hypothalamic GHRH for maximal GH stimulation. J Clin Endocrinol Metab 1998;83:1186-1189
14. Gelato MC, Malozowski S, Caruso-Nicoletti M, et al. Growth hormone (GH) responses to GHRH during pubertal development in normal boys and girls: Comparison to idiopathic short stature and GH deficiency. J Clin Endocrinol Metab 1986;63:174-179
15. Pavlov EP, Harman SM, Merriam GR, et al. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1986;62:595-600
16. Chapman IM, Hartman ML, Pezzoli SS, et al. Effect of aging on the sensitivity of GH secretion to insulin-like growth factor-I negative feedback. J Clin Endocrinol Metab 1997;82:2996-3004
17. Ghigo E, Goffi S, Nicolosi M, et al. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 1990;71:1481-1485
18. Arvat E, Giannoti L, Grottoli S, et al. Arginine and growth hormone-releasing hormone restore the blunted GH-releasing activity of hexarelin in elderly subjects. J Clin Endocrinol Metab 1994;79:1440-1443
19. Kelijman M, Frohman LA. Enhanced growth hormone (GH) responsiveness to GHRH after dietary manipulation in obese and non-obese subjects. J Clin Endocrinol Metab 1988;66:489-494
20. Rose SR, Kibarian M, Gelato MC, et al. Sex steroids increase spontaneous GH secretion in short children. J Pediatr Endocrinol 1988;3:1-5
21. Liu L, Merriam GR, Sherins RJ. Chronic sex steroid exposure increases mean plasma GH concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1987;64:651-656
22. Veldhuis JD, Metzger DL, Martha PM, et al. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (GH)-IGF-1 axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 1997;82:3414-3420
23. Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of GH secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-58
24. Wilshire GB, Loughlin JS, Brown JR, et al. Diminished function of the somatotropic axis in older reproductive-aged women. J Clin Endocrinol Metab 1995;80:608-613
25. Blake EJ, Adel T, Santoro N. Relationships between insulin-like growth factor-I and estradiol in reproductive aging. Fertil Steril 1997;67:697-701
26. Klein NA, Battaglia DE, Miller PB, Soules MR. Circulating levels of GH, insulin-like growth factor-I, and GH binding protein in normal women of advanced reproductive age. Clin Endocrinol (Oxf) 1996;44:285-292
27. 2 in men and women. J Clin Endocrinol Metab 1984;59:197-201
28. Veldhuis JD. Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human. Endocr Rev 1998;19:719-797
29. Bellantoni M, Vittone J, Campfield A, et al. Effects of oral vs. transdermal estrogen on the GH-insulin-like growth factor I axis in younger and older postmenopausal women. J Clin Endocrinol Metab 1996;81:2848-2853
30. Drake W, Coyte D, Camacho H, et al. Optimizing GH replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998;83:9313-9319
31. Cook DC, Ludlam WH, Cook MB. Route of estrogen administration helps to determine GH replacement dose in GH-deficient adults. J Clin Endocinol Metab 1999;84:3956-3960
32. Burman P, Johansson A, Siegbahn A, et al. Growth hormone deficient men are more responsive to GH replacement than women. J Clin Endocrinol Metab 1997;82:550-555
33. Yakar S, Liu J-L, Stannard B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor-I. Proc Natl Acad Sci U S A 1999;96:7324-7329
34. 2 in age-advanced men and women. J Clin Endocrinol Metab 1997;82:1472-1479
35. Merriam GR, Barsness S, Drolet G, et al. Effects of GHRH treatment on 24-hour GH secretion, IGF-I, and body fat in healthy older men and women. Endocrine Society, San Diego, 1999
36. Christ ER, Carroll PV, Russell JDL, Sonksen PH. The consequences of GH deficiency in adulthood, and the effects of GH replacement. Schweiz Med Wochenschr 1997;127:1440-1449
37. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The GH deficiency syndrome in adults. Clin Endocrinol (Oxf) 1992;37:387-397
38. Labram EK, Wilkin TJ. Growth hormone deficiency in adults and its response to GH replacement. QJM 1995;88:391-399
39. Ros'en T, Johannsson G, Johansson JO, Bengtsson BA. Consequences of GH deficiency in adults and the benefits and risks of recombinant human GH treatment. Horm Res 1995;43:93-99
40. Jorgensen JO, Muller J, Moller J, et al. Adult GH deficiency. Horm Res 1994;42:235-241
41. Lieberman SA, Hoffman AR. Growth hormone deficiency in adults: Characteristics and response to GH replacement. J Pediatr 1996;128:S58-S60
42. Ros'en T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-288
43. Bates AS, Van't HW, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996;81:1169-1172
44. Bengtsson BA. The consequences of GH deficiency in adults. Acta Endocrinol (Copenh) 1993;2:2-5
45. Harris MI. Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med 1990;6:703-719
46. Lamberts SWJ, Van den Beld AW, Van der Lely AJ. The endocrinology of aging. Science 1997;278:419-424
47. Ezzat S, Melmed S. Clinical review 18: Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 1991;72:245-249
48. Brunner JE, Johnson CC, Zafar S, et al. Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer. Clin Endocrinol (Oxf) 1990;32:65-71
49. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of IGF-1 and risk of breast cancer. Lancet 1998;351:1393-1396
50. Chan JM, Stampfer MJ, Giovanucci E, et al. Plasma IGF-1 and prostate cancer risk: A prospective study. Science 1998;279:563-566
51. Holly J. IGF-1 and new opportunities for cancer prevention. Lancet 1998;351:1373-1375
52. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency: Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-381
53. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with GH treatment in critically ill adults. N Engl J Med 1999;341:785-792
54. Iranmanesh A, Lizarralde G, Velduis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081-1088
55. Abbasi AA, Drinka PJ, Mattson DE, Rudman D. Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men. J Am Geriatr Soc 1993;41:975-982
56. Reutens AT, Veldhuis JD, Hoffman DM, et al. A highly sensitive GH ELISA uncovers increased contribution of a tonic mode of GH secretion in adults with organic GH deficiency. J Clin Endocrinol Metab 1996;81:1591-1597
57. Toogood AA, O'Neill PA, Shalet SM. Beyond the somatopause: GH deficiency in adults over the age of 60 years. J Clin Endocrinol Metab 1996;81:460-465
58. Toogood AA, Nass RM, Pezzoli SS, et al. Preservation of GH pulsatility despite pituitary pathology, surgery, and irradiation. J Clin Endocrinol Metab 1997;82:2215-2221
59. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. Diagnosis of growth-hormone deficiency in adults. Lancet 1994;343:1064-1068
60. Shalet SM, Toogood A, Rahim A, Brennan BMD. The diagnosis of GH deficiency in children and adults. Endocr Rev 1998;19:203-223
61. Rudman D, Feller AG, Nagraj HS, et al. Effects of human GH in men over 60 years old. N Engl J Med 1990;323:1-6
62. Rudman D, Feller AG, Cohn L, et al. Effects of human GH on body composition in elderly men. Horm Res 1991;36(suppl):73-81
63. Thompson JL, Butterfield GE, Marcus R, et al. The effects of recombinant human insulin-like growth factor-I and GH on body composition in elderly women. J Clin Endocrinol Metab 1995;80:1845-1852
64. Papadakis MA, Grady D, Black D, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124:708-716
65. Taaffe DR, Jin IH, Vu TH, et al. Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men. J Clin Endocrinol Metab 1996;81:421-425
66. Yarasheski KE, Campbell JA, Kohrt WM. Effect of resistance exercise and GH on bone density in older men. Clin Endocrinol 1997;47:223-229
67. Marcus R, Butterfield G, Holloway L, et al. Effects of short term administration of recombinant human GH to elderly people. J Clin Endocrinol Metab 1990;70:519-527
68. Aloia JF, Zanzi I, Ellis K, et al. Effects of GH in osteoporosis. J Clin Endocrinol Metab 1976;43:992-999
69. Holloway L, Butterfield G, Hintz RL, et al. Effects of recombinant human GH on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 1994;79:470-479
70. Erdtsieck RJ, Pols HA, Valk NK, et al. Treatment of postmenopausal osteoporosis with a combination of GH and pamidronate: A placebo controlled trial. Clin Endocrinol (Oxf) 1995;43:557-565
71. Marcus R, Hoffman AR. Growth hormone as therapy for older men and women. Annu Rev Pharmacol Toxicol 1998;38:45-61
72. Merriam GR, Cassorla F. Clinical and physiological studies with growth hormone-releasing hormone. In: Smith RG, Thorner MO, eds. Human Growth Hormone: Research and Clinical Practice. Totowa, NJ: Humana Press; 1999:297-313
73. Martin FC, Yeo A-L, Sonksen PH. Growth hormone secretion in the elderly: Aging and the somatopause. Baillieres Clin Endocrinol Metab 1997;11:223-250
74. Kojima M, Hosoda H, Date Y, Nakagato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660